These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


441 related items for PubMed ID: 5568474

  • 1. [Action of L-dopa in Parkinson's syndrome].
    Ucar S, Eiras J.
    Rev Clin Esp; 1971 Feb 15; 120(3):257-62. PubMed ID: 5568474
    [No Abstract] [Full Text] [Related]

  • 2. [L-dopa in Parkinson's syndrome].
    Filho RM, de Karam GM.
    Rev Bras Med; 1971 May 15; 28(5):220-31. PubMed ID: 5563096
    [No Abstract] [Full Text] [Related]

  • 3. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
    Lombardo L.
    Arch Invest Med (Mex); 1973 May 15; 4(3):215-24. PubMed ID: 4784173
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of Parkinson's syndrome with L-dopa. In operated and nonoperated cases].
    Pimenta Ada M, Friguglietti DJ.
    Rev Bras Med; 1971 Sep 15; 28(9):481-96. PubMed ID: 5139650
    [No Abstract] [Full Text] [Related]

  • 5. [L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
    Görlich J, Markus E.
    Dtsch Med Wochenschr; 1972 Aug 25; 97(34):1246-8. PubMed ID: 5048316
    [No Abstract] [Full Text] [Related]

  • 6. [Our first observations on Parkinson's disease or parkinsonian syndromes treated with L-dopa].
    Boudouresques J, Khalil R, Vigouroux RA, Gosset A, Daniel F, Dufour H.
    Mars Med; 1971 Aug 25; 108(2):85-9. PubMed ID: 5548385
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I.
    J Med Assoc State Ala; 1971 May 25; 40(11):709-18. PubMed ID: 5573008
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J, Dupont E, Mikkelsen B.
    Ugeskr Laeger; 1971 Nov 26; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)].
    Mazza C, Buffatti PF, Bazzan A, Lion P.
    Fracastoro; 1970 Nov 26; 63(5):768-73. PubMed ID: 5519378
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
    Schneider E, Fischer PA, Jacobi P.
    Med Klin; 1974 Mar 29; 69(13):541-5. PubMed ID: 4831456
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G, Castaigne P, Lhermitte F, Beck H, Guillard A, Marteau R, Pepin B, Rondot P, Raphy B.
    Rev Neurol (Paris); 1970 Feb 29; 122(2):89-102. PubMed ID: 4931719
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.